ReactomeFIViz: A cytoscape app for pathway and network-based data analysis

F1000Research

Volumn 3, Issue , 2014, Pages

  Wu, Guanming ^a,b   Dawson, Eric ^c   Duong, Adrian ^a   Haw, Robin ^a   Stein, Lincoln ^a,d  

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; THYMINE;

ARTICLE; CANCER GENETICS; CLIENT SERVER APPLICATION; COMPUTER INTERFACE; CYTOSCAPE; DATA ANALYSIS SOFTWARE; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE FUNCTION; GENE REGULATORY NETWORK; GENETIC DATABASE; INFORMATION PROCESSING; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; OVARY CANCER; PROBABILITY; RELIABILITY;

EID: 84914816545     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.4431.2     Document Type: Article

References (17)

1. Barabási AL Gulbahce N Loscalzo J: Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56-68. 21164525 10.1038/nrg2918 3140052
2. Vidal M Cusick ME Barabási AL: Interactome networks and human disease. Cell. 2011;144(6):986-998. 21414488 10.1016/j.cell.2011.02.016 3102045
3. Wu G Feng X Stein L: A human functional protein interaction network and its application to cancer data analysis. Genome Biol. 2010;11(5):R53. 20482850 10.1186/gb-2010-11-5-r53 2898064
4. Croft D Mundo AF Haw R: The Reactome pathway knowledgebase. Nucleic Acids Res. 2014;42(Database issue):D472-7. 24243840 10.1093/nar/gkt1102 3965010
5. Vandin F Upfal E Raphael BJ: Algorithms for detecting significantly mutated pathways in cancer. J Comput Biol. 2011;18(3):507-22. 21385051 10.1089/cmb.2010.0265
6. Vandin F Clay P Upfal E: Discovery of mutated subnetworks associated with clinical data in cancer. Pac Symp Biocomput. 2012;55-66. 22174262 10.1142/9789814366496_0006
7. Wu G Stein L: A network module-based method for identifying cancer prognostic signatures. Genome Biol. 2012;13(12):R112. 23228031 10.1186/gb-2012-13-12-r112 3580410
8. Huang da W Sherman BT Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucl Acids Res. 2009;37(1):1-13. 19033363 10.1093/nar/gkn923 2615629
9. Vaske CJ Benz SC Sanborn JZ: Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics. 2010;26(12):i237-45. 20529912 10.1093/bioinformatics/btq182 2881367
10. Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7363):609-15. 21720365 10.1038/nature10166 3163504
11. Kleinbaum DG Klein M: Survival Analysis: A Self Learning Guide. New York: Springer.2005. Reference Source
12. Cox D: Regression Models and Life Tables (with Discussion). J R Stat Soc B. 1972;34(2):187-220. Reference Source
13. Shah SP Roth A Goya R: The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395-9. 22495314 10.1038/nature10933 3863681
14. Sawey ET Chanrion M Cai C: Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell. 2011;19(3):347-58. 21397858 10.1016/j.ccr.2011.01.040 3061399
15. Tamborero D Gonzalez-Perez A Perez-Llamas C: Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep. 2013;3:2650. 24084849 10.1038/srep02650 3788361
16. Kalatskaya I Wu G: Pathway and network based analysis using Functional Interaction network. Genomics II Bacteria, Viruses and Metabolic PathwaysiConcept.2013. Reference Source
17. Wu G Dawson E Duong A: Reactome FI Cytoscape plugin. Zenodo. 2014. Data Source